TABLE 12.
PROPORTION OF PATIENTS WITH VISUAL ACUITY 20/200 OR BETTER, BY TUMOR LOCATION (SMALL/MEDIUM TUMORS)
| TIME POST TX | 12 MONTHS | 24 MONTHS | ||||
|---|---|---|---|---|---|---|
| Tumor Location |
RBZ + PBI (%) |
PBI (%) |
P^ |
RBZ + PBI(%) |
PBI (%) |
P^ |
| ≤ 2DD from both optic disc and fovea | 11/11 (100) | 39/48 (81.3) | .13 | 11/11 (100) | 22/37 (59.5) | .009 |
| ≤ 2DD from fovea and > 2DD from optic disc | 8/8 (100) | 15/16 (93.8) | .67 | 8/8 (100) | 13/14 (92.9) | .64 |
| ≤ 2DD from optic disc and > 2DD from fovea | 5/5 (100) | 14/15 (93.3) | .75 | 5/5 (100) | 8/11 (72.7) | .29 |
^
Fisher’s exact test
Tx:treatment; RBZ: ranibizumab; PBI: proton beam irradiation